tiprankstipranks
Trending News
More News >
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
Canadian Market

Britannia Life Sciences Inc (BLAB) Ratios

Compare
1 Followers

Britannia Life Sciences Inc Ratios

TSE:BLAB's free cash flow for Q3 2024 was C$0.58. For the 2024 fiscal year, TSE:BLAB's free cash flow was decreased by C$ and operating cash flow was C$0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
0.92 0.92 0.42 0.25 0.21
Quick Ratio
0.92 0.92 0.42 0.25 0.20
Cash Ratio
0.57 0.57 0.20 0.08 0.19
Solvency Ratio
0.43 0.43 -0.98 >-0.01 -0.53
Operating Cash Flow Ratio
0.26 0.26 0.34 -0.06 -0.44
Short-Term Operating Cash Flow Coverage
0.61 0.61 0.57 -0.07 -0.66
Net Current Asset Value
C$ -8.27MC$ -8.27MC$ -12.12MC$ -16.27MC$ -10.79M
Leverage Ratios
Debt-to-Assets Ratio
0.36 0.36 0.25 0.49 2.95
Debt-to-Equity Ratio
1.20 1.20 3.84 -52.12 -0.93
Debt-to-Capital Ratio
0.54 0.54 0.79 1.02 -12.66
Long-Term Debt-to-Capital Ratio
0.47 0.47 0.08 1.09 -0.17
Financial Leverage Ratio
3.35 3.35 15.59 -106.02 -0.31
Debt Service Coverage Ratio
2.44 2.44 -1.59 -0.23 -0.56
Interest Coverage Ratio
0.21 0.21 0.16 0.32 -3.03
Debt to Market Cap
0.54 0.54 0.24 6.47 5.96
Interest Debt Per Share
0.06 0.06 0.07 1.85 1.90
Net Debt to EBITDA
0.84 0.84 -0.33 -6.01 -1.34
Profitability Margins
Gross Profit Margin
72.43%72.43%72.08%82.24%29.29%
EBIT Margin
104.81%104.81%-150.15%-118.42%-555.03%
EBITDA Margin
108.61%108.61%-147.55%-113.54%-549.62%
Operating Profit Margin
2.78%2.78%5.20%8.06%-534.22%
Pretax Profit Margin
91.48%91.48%-181.84%28.12%-731.50%
Net Profit Margin
79.39%79.39%-211.76%-11.03%-731.50%
Continuous Operations Profit Margin
91.45%91.45%-191.59%10.04%-731.50%
Net Income Per EBT
86.78%86.78%116.45%-39.23%100.00%
EBT Per EBIT
3295.78%3295.78%-3497.28%348.90%136.93%
Return on Assets (ROA)
21.59%21.59%-73.30%-0.73%-225.23%
Return on Equity (ROE)
72.39%72.39%-1142.96%77.68%70.72%
Return on Capital Employed (ROCE)
0.94%0.94%2.97%1.02%60.63%
Return on Invested Capital (ROIC)
0.84%0.84%2.26%0.21%717.19%
Return on Tangible Assets
85.57%85.57%-383.50%-4.89%-277.08%
Earnings Yield
33.00%33.00%-74.30%-9.86%-454.66%
Efficiency Ratios
Receivables Turnover
4.01 4.01 4.07 0.84 13.12
Payables Turnover
0.78 0.78 0.69 0.12 0.39
Inventory Turnover
0.00 0.00 0.00 80.69 11.80
Fixed Asset Turnover
14.16 14.16 13.37 2.03 8.41
Asset Turnover
0.27 0.27 0.35 0.07 0.31
Working Capital Turnover Ratio
-2.46 -2.46 -1.17 -0.17 -0.26
Cash Conversion Cycle
-375.43 -375.43 -440.89 -2.49K -886.05
Days of Sales Outstanding
91.04 91.04 89.62 432.01 27.82
Days of Inventory Outstanding
0.00 0.00 0.00 4.52 30.93
Days of Payables Outstanding
466.47 466.47 530.52 2.93K 944.79
Operating Cycle
91.04 91.04 89.62 436.53 58.75
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 0.03 -0.10 -0.89
Free Cash Flow Per Share
<0.01 <0.01 0.02 -0.09 -0.90
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
0.72 0.72 0.97 0.93 1.01
Dividend Paid and CapEx Coverage Ratio
3.55 3.55 32.15 -13.61 -75.79
Capital Expenditure Coverage Ratio
3.55 3.55 32.15 -13.61 -75.79
Operating Cash Flow Coverage Ratio
0.14 0.14 0.54 -0.06 -0.55
Operating Cash Flow to Sales Ratio
0.19 0.19 0.38 -0.41 -5.32
Free Cash Flow Yield
5.68%5.68%13.04%-34.11%-334.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.03 3.03 -1.35 -10.14 -0.22
Price-to-Sales (P/S) Ratio
2.41 2.41 2.85 1.12 1.61
Price-to-Book (P/B) Ratio
2.19 2.19 15.38 -7.87 -0.16
Price-to-Free Cash Flow (P/FCF) Ratio
17.62 17.62 7.67 -2.93 -0.30
Price-to-Operating Cash Flow Ratio
12.66 12.66 7.43 -2.72 -0.30
Price-to-Earnings Growth (PEG) Ratio
-0.02 -0.02 >-0.01 0.10 <0.01
Price-to-Fair Value
2.19 2.19 15.38 -7.87 -0.16
Enterprise Value Multiple
3.05 3.05 -2.26 -6.99 -1.63
Enterprise Value
21.21M 21.21M 24.37M 11.31M 8.73M
EV to EBITDA
3.05 3.05 -2.26 -6.99 -1.63
EV to Sales
3.31 3.31 3.34 7.94 8.96
EV to Free Cash Flow
24.26 24.26 8.98 -20.81 -1.66
EV to Operating Cash Flow
17.44 17.44 8.70 -19.28 -1.68
Tangible Book Value Per Share
-0.04 -0.04 -0.11 -2.64 -1.84
Shareholders’ Equity Per Share
0.04 0.04 0.01 -0.03 -1.74
Tax and Other Ratios
Effective Tax Rate
<0.01 <0.01 -0.05 0.64 >-0.01
Revenue Per Share
0.04 0.04 0.07 0.24 0.17
Net Income Per Share
0.03 0.03 -0.14 -0.03 -1.23
Tax Burden
0.87 0.87 1.16 -0.39 1.00
Interest Burden
0.87 0.87 1.21 -0.24 1.32
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.53 0.53 1.84 0.53 0.47
Stock-Based Compensation to Revenue
0.16 0.16 0.15 -0.20 0.00
Income Quality
0.21 0.21 -0.20 -4.10 0.73
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis